Bajaj Broking Research recommends Piramal Pharma and PTC India for the upcoming week. Nifty is expected to remain volati ...

PTC Therapeutics, Inc. today shared new data being presented from the Phase 3 APHENITY trial and subsequent open-label extension study at the 2025 American College of Medical Genetics and Genomics ...

Learn more about whether PTC Therapeutics, Inc. or Sarepta Therapeutics, Inc. is a better investment based on AAII's A+ ...

Benchmark stock indices opened the week on a positive trajectory, bringing much-needed relief to Dalal Street investors. The ...

With a promising outlook for PTC India and Piramal Pharma, Bajaj Broking identifies key stock picks poised for over 15% ...

The stock market is expected to remain directionless next week, but experts have identified eight stocks that could ...

Duska noted that the PD-L1 inhibitor pembrolizumab has shown efficacy in the treatment of recurrent or metastatic cervical ...

On Friday, March 21, several stocks across sectors are expected to remain in focus. Gift Nifty Today, March 21. It indicated ...

In a report released yesterday, Kristen Kluska from Cantor Fitzgerald maintained a Buy rating on Sarepta Therapeutics (SRPT – Research Report), ...

Detailed price information for Disc Medicine Inc (IRON-Q) from The Globe and Mail including charting and trades.

PTC, a digital technology firm working across multiple industries, offers AR technology to pharmaceutical companies to deliver training. The difference from the use of VR tools is that the ...